The rise of breast cancer incidence over the past years is attributed to the increase in hormone receptor/estrogen receptor (ER)-positive breast cancers with a simultaneous reduction in ER-negative breast cancers (1). This evidence concerns the gene NR4A1 and breast carcinoma.